Skip to main content

Table 4 Prevalence of CSP antibodies seropositivity in children who never received SMC and children that SMC for one, two and three years

From: Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

 

n

%

95% CI

Unadjusted

Adjusteda

OR

95% CI

p

OR

95% CI

p

No SMC

141

89.2

84.4–94.1

Ref

–

–

Ref

–

–

SMC 1Y

215

79.3

74.5–84.2

0.46

0.25–0.82

0.010

0.49

0.27–0.89

0.021

SMC 2Y

186

80.2

75.0–85.3

0.48

0.26–0.88

0.018

0.53

0.28–0.97

0.041

SMC 3Y

185

80.1

74.9–85.3

0.48

0.26–0.88

0.018

0.54

0.29–1.00

0.05

SMC 1–3Y

586

79.8

0.76–0.82

0.47

0.27–0.81

0.007

0.52

0.30–0.90

0.019

  1. SMC 1Y received SMC for 1 year, SMC 2Y received SMC for 2 years, SMC 3Y received SMC for 3 years, SMC 1–3Y received SMC for 1, 2, or 3 years
  2. aAdjusted for age, gender and parasitemia
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us